New York State Common Retirement Fund Alpine Immune Sciences, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.75 - $41.6 $49,380 - $115,731	2,782 Added 18.7%	17,657 $700,000
Q4 2023 Feb 01, 2024	BUY	$8.54 - $20.22 $44,758 - $105,973	5,241 Added 54.4%	14,875 $284,000
Q3 2023 Nov 07, 2023	BUY	$10.13 - $13.98 $42,090 - $58,086	4,155 Added 75.84%	9,634 $110,000
Q2 2023 Aug 07, 2023	SELL	$6.84 - $11.91 $177 - $309	-26 Reduced 0.47%	5,479 $56,000
Q1 2023 May 02, 2023	BUY	$7.0 - $8.75 $476 - $595	68 Added 1.25%	5,505 $42,000
Q3 2022 Nov 08, 2022	BUY	$6.89 - $9.39 $275 - $375	40 Added 0.74%	5,437 $39,000
Q4 2021 Feb 02, 2022	SELL	$10.41 - $13.95 $208 - $279	-20 Reduced 0.37%	5,397 $75,000
Q3 2021 Nov 02, 2021	SELL	$8.19 - $11.31 $39,991 - $55,226	-4,883 Reduced 47.41%	5,417 $58,000
Q2 2021 Aug 02, 2021	BUY	$8.81 - $15.03 $90,743 - $154,809	10,300 New	10,300 $93,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.